지씨플루프리필드시린지주(인플루엔자분할백신) (수출명: 지씨플루프리필드시린지주)
(주)녹십자
/
[구분] 의약품
/
[품목] [06310]백신류
/
[성분] 정제불활화인플루엔자바이러스항원A형[A/Thailand/8/2022 IVR-237(H3N2)]/정제불활화인플루엔자바이러스항원A형[A/Thailand/8/2022 IVR-237(H3N2)]/정제불활화인플루엔자바이러스항원A형[A/Thailand/8/2022 IVR-237(H3N2)]/정제불활화인플루엔자바이러스항원A형[A/Thailand/8/2022 IVR-237(H3N2)]/정제불활화인플루엔자바이러스항원A형[A/Victoria/4897/2022 IVR-238(H1N1)]/정제불활화인플루엔자바이러스항원A형[A/Victoria/4897/2022 IVR-238(H1N1)]/정제불활화인플루엔자바이러스항원A형[A/Victoria/4897/2022 IVR-238(H1N1)]/정제불활화인플루엔자바이러스항원A형[A/Victoria/4897/2022 IVR-238(H1N1)]/정제불활화인플루엔자바이러스항원B형[B/Austria/1359417/2021 BVR-26]/정제불활화인플루엔자바이러스항원B형[B/Austria/1359417/2021 BVR-26]/정제불활화인플루엔자바이러스항원B형[B/Austria/1359417/2021 BVR-26]/정제불활화인플루엔자바이러스항원B형[B/Austria/1359417/2021 BVR-26]
/
[식약처 품목기준코드] 200905819
/
[도움닥 등록일] 2024-04-13 19:38:21